Virax Biolabs Group Ltd.

VRAX·NASDAQ·$0.23Share Price as of 11/2·$985,624Market Cap as of 11/2

Financials

20-FAnnual report (foreign)07/06/26 20-FAnnual report (foreign)07/02/25 20-FAnnual report (foreign)08/20/24 20-FAnnual report (foreign)06/14/23 20-FAnnual report (foreign)08/12/22

Disclosures

6-KForeign issuer report10/29/26 6-KForeign issuer report10/09/26 6-KForeign issuer report09/04/26 6-KForeign issuer report08/26/26 6-KForeign issuer report08/18/26

Prospectuses and Registrations

424B3Prospectus09/10/26 424B5Prospectus supplement09/04/26 F-3/AShelf registration (foreign, amended)09/02/26 F-3Shelf registration (foreign)07/24/26 424B3Prospectus12/31/25

Proxies

No matching filings.

Ownership

Form 3Initial insider ownership10/21/26 SC 13G/ABeneficial ownership (amended)05/15/26 Form 3Initial insider ownership03/31/26 Form 3Initial insider ownership03/20/26 Form 3Initial insider ownership03/18/26

Other

EFFECTRequest for effectiveness09/03/26 EFFECTRequest for effectiveness12/30/25 CORRESPCorrespondence with the SEC12/29/25 DD12/18/25 NT 20-FLate filing notification (20-F)08/01/24